Drug Type Small molecule drug |
Synonyms Januvia/Zocor, Juvicor, Juvisync + [6] |
Target |
Action inhibitors |
Mechanism DPP-4 inhibitors(Dipeptidyl peptidase IV inhibitors), HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (07 Oct 2011), |
Regulation- |
Molecular FormulaC16H20F6N5O6P |
InChIKeyGQPYTJVDPQTBQC-KLQYNRQASA-N |
CAS Registry654671-77-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Coronary Artery Disease | United States | 07 Oct 2011 | |
Coronary Disease | United States | 07 Oct 2011 | |
Diabetes Mellitus, Type 2 | United States | 07 Oct 2011 | |
Dyslipidemias | United States | 07 Oct 2011 | |
Homozygous familial hypercholesterolemia | United States | 07 Oct 2011 | |
Hypercholesterolemia | United States | 07 Oct 2011 | |
Hyperlipoproteinemia Type III | United States | 07 Oct 2011 | |
Hypertriglyceridemia | United States | 07 Oct 2011 | |
Myocardial Infarction | United States | 07 Oct 2011 | |
Stroke | United States | 07 Oct 2011 |
Phase 3 | 299 | (Sitagliptin/Simvastatin FDC) | zcoyoqldvd(roaruycvxq) = ioiwznmocm fjhqmiokmy (dtyvfzaldv, avmtllmpae - asvekezxkl) View more | - | 22 Oct 2014 | ||
(Sitagliptin) | zcoyoqldvd(roaruycvxq) = qxmtyvqkzg fjhqmiokmy (dtyvfzaldv, vvcghrnloe - jatyatejxf) View more | ||||||
Phase 3 | 42 | fppyqikytv(luwbepwmhm) = nqekmcwdri pewjevwacp (hqbgxoskrm, vtviiijovr - lfwlalwayl) View more | - | 30 May 2014 |